Target intelligence / Profile preview

GPN-loop GTPase 3 pseudogene 1 (GPN3P1)

Target: GPN3P1
Molecular classification: Other (Pseudogene)

Overview

GPN-loop GTPase 3 pseudogene 1 (GPN3P1) is a pseudogene, not a protein-coding gene or functional target. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they do not encode functional proteins and lack biological or pharmacological activity. No direct biological function, disease role, or drug interactions have been reported for GPN3P1. Thus, it is not considered a therapeutic target[1]. GPN3P1 is distinct from GPN-loop GTPase 3 (GPN3), which is a protein-coding gene involved in RNA polymerase II localization and has known biological roles[5][7]. GPN3P1 does not share these properties as it is a pseudogene[1].

Other names: GPN3P1

Beyond the preview

Go deeper on GPN-loop GTPase 3 pseudogene 1 (GPN3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPN-loop GTPase 3 pseudogene 1 (GPN3P1).

Explore the full profile